Drugs / H057
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06958861 | May 2025 → May 2027 expected | bronchiectasis | Shanghai Huilun Pharmaceutical Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H057 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06958861 ↗ |
| Route | Inhaled | “administered low-dose inhaled H057” NCT06958861 ↗ |